Applied DNA Sciences (NASDAQ:APDN) issued an update on its fourth quarter earnings guidance on Friday morning. The company provided earnings per share guidance of ($0.10) for the period, compared to the Thomson Reuters consensus earnings per share estimate of ($0.11). The company issued revenue guidance of $1.1 million, compared to the consensus revenue estimate of $1.90 million.

Shares of Applied DNA Sciences (NASDAQ APDN) opened at $2.57 on Friday. Applied DNA Sciences has a 1-year low of $0.90 and a 1-year high of $3.45.

Several analysts recently issued reports on APDN shares. Maxim Group set a $5.00 price objective on Applied DNA Sciences and gave the stock a buy rating in a report on Friday, December 8th. ValuEngine upgraded Applied DNA Sciences from a strong sell rating to a sell rating in a report on Tuesday, October 3rd.

ILLEGAL ACTIVITY WARNING: This story was first posted by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this story can be read at

About Applied DNA Sciences

Applied DNA Sciences, Inc is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon.

Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with's FREE daily email newsletter.